CYTORA LTD
General Data
Reg Number
515246775
Sector
Biomed
Established
2015
No. of Employees
8
Stage
R&D
Additional Funding
1
Description
• CYTORA is a clinical stage stem-cell company developing a new class of “Off the Shelf” medicines based on a novel & transformative patented platform technology derived from unique human Oral Mucosa Stem Cells (hOMSC).
Technology
Cytora develops stem cell therapies, based on a unique patented platform technology of a highly potent stem cell population. hOMSC administration to wounds of diabetic mouse model (db/db) equalizes the rate of wound closure to the natural rate of wound closure in healthy animals (WT-untreated).
Targeted Customers
People suffering from diabetes.
Management personnel
Yona Geffen - CEO
Winning details
Route name
Winning year
The Expedited Program
The Expedited Program
2023
Development to manufactor
Development to manufactor
2024
Development to manufactor
Development to manufactor
2025